Evidence map›Paper›PMID 33462791›Full record

Observational studyJournal of neurovirology2021

HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil.

Sérgio Monteiro de Almeida, Indianara Rotta, Luine Rosele Renaud Vidal, Jucelia Stadinicki Dos Santos, Avindra Nath, Kory Johnson, Scott Letendre, Ronald J Ellis, H. I. V. Neurobehavioral Research Center (HNRC) Group

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of neurovirology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cerebrospinal fluid CD14Journal of neurovirology · 2023
    Article
  6. CD3Journal of neuroimmunology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Addressing an HIV cure in LMIC.Retrovirology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sérgio Monteiro de AlmeidaUniversidade Federal Do Paraná, Curitiba, Paraná, Brazil. sergio.ma@ufpr.br.ORCID 0000-0001-5690-105X
Indianara RottaUniversidade Federal Do Paraná, Curitiba, Paraná, Brazil.
Luine Rosele Renaud VidalUniversidade Federal Do Paraná, Curitiba, Paraná, Brazil.
Jucelia Stadinicki Dos SantosUniversidade Federal Do Paraná, Curitiba, Paraná, Brazil.
Avindra NathNational Institute of Neurological Disorders and Stroke, NIH/NINDS, Bethesda, USA.
Kory JohnsonNational Institute of Neurological Disorders and Stroke, NIH/NINDS, Bethesda, USA.
Scott LetendreUniversity of California-San Diego, San Diego, CA, USA.
Ronald J EllisUniversity of California-San Diego, San Diego, CA, USA.
H. I. V. Neurobehavioral Research Center (HNRC) Group
National Institute of Neurological Disorders and Stroke · USUniversity of California San Diego · USUniversidade Federal do Paraná · BR

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Neuropathogenesis of Retroviral InfectionsZIANS003130 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI NATH, AVINDRA · 2011 to 2025
$73.7M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
HIV Clade on Cognitive and Neurological Disorders BrazilR21MH076651 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLIS, RONALD J. · 2006 to 2007
$317k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIMH NIH HHS P30 MH062512NIMH NIH HHS R21 MH076651NIMH NIH HHS R21 MH076651-01
6 · The paper itself

Abstract

The transactivator of transcription (Tat) is a key HIV regulatory protein. We aimed to identify the frequency of key polymorphisms in HIV-1C compared with HIV-1B Tat protein, chiefly in the cysteine-, arginine-, and glutamine-rich domains and identify novel point mutations in HIV-1B and C sequences from Southern Brazil. This study was the first to investigate the genetic diversity and point mutations within HIV-1 Tat C in a Brazilian cohort. This was an observational, cross-sectional study, which included sequences of HIV-1B (n = 20) and HIV-1C (n = 21) from Southern Brazil. Additionally, 344 HIV-1C sequences were obtained from the Los Alamos database: 29 from Brazil and 315 from Africa, Asia, and Europe. The frequency of C31S substitution on HIV-1 Tat C in Brazil was 82% vs. 10% in the HIV-1B group (p < 0.0001). The frequency of the R57S substitution among the HIV-1C sequences from Brazil was 74% vs. 20% in HIV-1B (p = 0.004), and that of substitution Q63E in HIV-1C was 80% and 20% in HIV-1B (p < 0.0001). The mutation P60Q was more frequent in HIV-1B than in HIV-1C (55% and 6.12%, respectively, p < 0.0001)). Novel point mutations in the HIV-1C and B Tat functional domains were described. The frequency of C31S and other key point mutations in HIV-1 Tat C in Brazil were similar to those described in Africa, although lower than those in India. The Tat-B and C sequences found in Southern Brazil are consistent with biological differences and have potential implications for HIV-1 subtype pathogenesis.

Indexed as

AdultBrazilCross-Sectional StudiesFemaleHIV-1HumansMaleMiddle AgedPolymorphism, Single Nucleotidetat Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency VirusDicysteineHIV-1NeuropathogenesisPolymorphismSubtype CTat

Identifiers

PMID33462791
PMCPMC8510567
OpenAlexW3122931800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.